Frontlight ResearchEarly access
Haemophilia trials in United States
16 of 43 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Study to Learn About the Study Medicine (Called Marstacimab) in People With Hemophilia A or B
- Where
- New York
- Age
- 6 years and over
- People
- 100
- Run by
- Pfizer
See details and how to joinNCT07859527 - No phaseNot yet taking people in United StatesAn Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Children With Hemophilia A
- Where
- Loma Linda, New Brunswick
- Age
- 7 years to 12 years
- People
- 40 worldwide
- Run by
- Bayer
See details and how to joinNCT07088458 - No phaseNot yet taking people in United StatesA Study to Describe Patient REal-world FitusiRan ExpeRience
- Where
- Indianapolis
- Age
- 12 years and over
- People
- 100
- Run by
- Sanofi
See details and how to joinNCT07895381 - No phaseNot yet taking people in United StatesLiver Biopsy Following Gene Therapy For Hemophilia
- Where
- Memphis
- Age
- 18 years to 80 years
- People
- 8
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT05932914 - No phaseTaking peopleA Prospective Assessment of Bone Health in Patients With Severe Hemophilia A on Factor VIII vs Factor Mimetic Prophylaxis (Efa Emi Bone Health Study)
- Where
- Little Rock
- Age
- 30 years to 50 years
- People
- 50
- Run by
- Arkansas Children's Hospital Research Institute
See details and how to joinNCT07582276 - No phaseTaking peopleTG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
- Where
- Dallas
- Age
- 6 months and over
- People
- 60
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT07692217 - Phase 4Taking peopleTreatment of Hemophilia A Patients With FVIII Inhibitors
- Where
- Atlanta
- People
- 120 worldwide
- Run by
- Emory University
See details and how to joinNCT04023019 · EU 2024-516741-39-00 - No phaseTaking peoplePharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Where
- Albuquerque, Aurora, Austin, Baltimore, Boston, Chapel Hill, Charleston, Chicago, Cincinnati, Columbia, Dallas, Durham, Hershey, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kansas City, Lebanon, Lexington, Little Rock, Los Angeles, Louisville, Madison, Milwaukee, Minneapolis, Morgantown, Nashville, New Orleans, Oklahoma City, Omaha, Palo Alto, Phoenix, Portland, Providence, Salt Lake City, Seattle, Sioux Falls, Wilmington
- Age
- 0 years to 20 years
- People
- 5,000 worldwide
- Run by
- Duke University
See details and how to joinNCT04278404 - No phaseTaking peopleATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Where
- Akron, Albuquerque, Atlanta, Austin, Baltimore, Boston, Buffalo, Chapel Hill, Charlotte, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Dayton, Detroit, Gainesville, Green Bay, Greenville, Hartford, Houston, Hyde Park, Indianapolis, Iowa City, Kansas City, Las Vegas, Little Rock, Los Angeles, Memphis, Miami, Milwaukee, Nashville, Newark, New Haven, New Orleans, New York, Norfolk, Oakland, Orlando, Peoria, Philadelphia, Phoenix, Pittsburgh, Providence, Reno, Rochester, Sacramento, San Antonio, San Bernardino, San Diego, San Francisco, Savannah, Scarborough, Seattle, St Louis, St. Petersburg, Tampa, The Bronx, Toledo, Washington D.C., Wilmington, Winston-Salem
- People
- 3,000
- Run by
- American Thrombosis and Hemostasis Network
See details and how to joinNCT04398628 - No phaseTaking peoplePrevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
- Where
- Boston, Chicago, Cincinnati, Detroit, Indianapolis, Little Rock, Oklahoma City, Palo Alto, San Diego, St. Petersburg
- Age
- 6 years to 19 years
- People
- 72
- Run by
- Wayne State University
See details and how to joinNCT05022459 - No phaseTaking peopleEfficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- Where
- Las Vegas, Miami, New Orleans, San Antonio, St Louis
- People
- 200 worldwide
- Run by
- Octapharma
See details and how to joinNCT03695978 - No phaseTaking peopleATHNdataset Registry
- Where
- Hickory
- People
- 200,000
- Run by
- American Thrombosis and Hemostasis Network
See details and how to joinNCT06820515 - No phaseTaking peopleAn Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
- Where
- Rochester
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- CSL Behring
See details and how to joinNCT06008938 - No phaseTaking peopleHemophilia A Research Program
- Where
- Seattle
- People
- 500
- Run by
- University of Washington
See details and how to joinNCT07414511 - Phase 4Enrolling by invitationA Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
- Where
- Ann Arbor, Aurora, Columbus, Detroit, Los Angeles, Louisville, Pittsburgh, Sacramento, San Diego, San Francisco, Shandon, St Louis, Tampa
- Age
- 18 years and over
- People
- 172 worldwide
- Run by
- BioMarin Pharmaceutical
See details and how to joinNCT05768386 · EU 2023-507749-27-00 - Phase 2/3Enrolling by invitationLong-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
- Where
- Ann Arbor, Aurora, Chapel Hill, Houston, Little Rock, Los Angeles, Nashville, Phoenix, Portland, Sacramento, Salt Lake City, San Diego, Seattle, Tampa
- Age
- 18 years and over
- People
- 56 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05962398 · EU 2023-503765-37-00